Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.66)
# 3,195
Out of 4,761 analysts
22
Total ratings
31.58%
Success rate
2.14%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $16.27 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $10.98 | +526.14% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $0.62 | +1,033.60% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $1.07 | +1,301.87% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $60 | $1.16 | +5,072.41% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $56.07 | -37.58% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $1.00 | +4,900.00% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $130 → $80 | $0.96 | +8,242.02% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $7.99 | +1,214.14% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $35.39 | -18.06% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $2.69 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $16.27
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $10.98
Upside: +526.14%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $0.62
Upside: +1,033.60%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.07
Upside: +1,301.87%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $60
Current: $1.16
Upside: +5,072.41%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $56.07
Upside: -37.58%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $1.00
Upside: +4,900.00%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130 → $80
Current: $0.96
Upside: +8,242.02%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $7.99
Upside: +1,214.14%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $35.39
Upside: -18.06%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $2.69
Upside: -